Search results
Results from the WOW.Com Content Network
Cannabidiol (CBD) is a phytocannabinoid, one of 113 identified cannabinoids in cannabis plants, along with tetrahydrocannabinol (THC), and accounts for up to 40% of the plant's extract. [16] Medically, it is an anticonvulsant used to treat multiple forms of epilepsy . [ 4 ]
A 2021 review found little effect of using non-inhaled cannabis to relieve chronic pain. [8] According to a 2019 systematic review, there have been inconsistent results of using cannabis for neuropathic pain, spasms associated with multiple sclerosis and pain from rheumatic disorders, but
CBD (short for cannabidiol) ... Gendai Echezona, MD, fellowship-trained, triple board-certified anesthesiologist specializing in interventional pain management and lifestyle medicine.
Nabilone can increase – rather than decrease – postoperative pain. [citation needed] In the treatment of fibromyalgia, adverse effects limit the useful dose. [4]Adverse effects of nabilone include, but are not limited to: dizziness/vertigo, euphoria, drowsiness, dry mouth, ataxia, sleep disturbance, headache, nausea, disorientation, depersonalization, hallucinations, and asthenia.
From Our Partners. For premium support please call: 800-290-4726 more ways to reach us
There is emerging evidence that cannabidiol may help slow cell damage in diabetes mellitus type 1. [30] There is a lack of meaningful evidence of the effects of medical cannabis use on people with diabetes; a 2010 review concluded that "the potential risks and benefits for diabetic patients remain unquantified at the present time". [31]
“Today’s approval is an important public health milestone in acute pain management,” Jacqueline Corrigan-Curay, acting director of the FDA’s Center for Drug Evaluation and Research, said ...
A systematic review in 2014 by the American Academy of Neurology found that nabiximols was 'probably effective' for spasticity, pain, and urinary dysfunction, but wasn't supported for tremor. [20] A 2021 study, however, showed “clinically relevant symptomatic results” [21] Nabiximols has also been studied for cancer pain resistant to opioids.